The private equity firm Exponent has acquired Ireland’s biggest generics producer, Chanelle Pharma, following past media reports of the pharma’s nearing sale, which estimated the price north of €300m.
The private equity firm Exponent has acquired what it described as Ireland’s biggest generics manufacturer, Chanelle Pharma, for an undisclosed sum of money. While the financial details of the transaction have not been made public, current media reports state that the figure could potentially be around €300m ($323m).
On 15 January this year, The Times had reported that the company was exploring a sale for €400m with the...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
